Brevan Howard Capital Management LP Precigen, Inc. Transaction History
Brevan Howard Capital Management LP
- $17 Billion
- Q3 2025
A detailed history of Brevan Howard Capital Management LP transactions in Precigen, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 123,742 shares of PGEN stock, worth $570,450. This represents 0.0% of its overall portfolio holdings.
Number of Shares
123,742Holding current value
$570,450% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PGEN
# of Institutions
188Shares Held
194MCall Options Held
6.61MPut Options Held
2.06M-
Third Security, LLC83.5MShares$385 Million73.5% of portfolio
-
Patient Capital Management, LLC Baltimore, MD26.5MShares$122 Million4.02% of portfolio
-
Tang Capital Management LLC San Diego, CA12.4MShares$57.2 Million1.85% of portfolio
-
Black Rock Inc. New York, NY10.2MShares$47.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.94MShares$41.2 Million0.0% of portfolio
About PRECIGEN, INC.
- Ticker PGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 208,150,000
- Market Cap $960M
- Description
- Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...